Synopsis
Analysis of contracts countries are signing with vaccine makers for advance booking of candidates shows that the deals are still fluid, changing in a matter of days with some companies gaining and some losing orders given that most candidates are still in trial stage.
(This story originally appeared in on Dec 14, 2020)BENGALURU: Overall global orders to secure vaccines shrunk 19.2 million doses to touch 7.1 billion as of December 11, compared to 7.12 billion as of November 30. India, which had deals for 1.6 billion doses by the end of last month has 1.5 billion as per data from Duke University’s Launch & Scale Speedometer, which is tracking global vaccine deals daily.
BENGALURU: Overall global orders to secure vaccines shrunk 19.2 million doses to touch 7.1 billion as of December 11, compared to 7.12 billion as of November 30. India, which had deals for 1.6 billion doses by the end of last month has 1.5 billion as per data from Duke University’s Launch & Scale Speedometer, which is tracking global vaccine deals daily.
Analysis of contracts countries are signing with vaccine makers for advance booking of candidates shows that the deals are still fluid, changing in a matter of days with some companies gaining and some losing orders given that most candidates are still in trial stage.
Among vaccine makers, orders with Oxford-Astrazeneca shrunk more than 30 million doses to touch 2.47 billion, compared to 2.5 billion as of November 30, while Pfizer-BioNTech vaccine, the only to be administered to people so far, saw additional orders for 73.2 million to touch 719 million as of December 11. Moderna saw fresh deals for 29 million doses.